San Diego Life Sciences Roundup: Halozyme, Skylight, NuSI, & More
(Page 2 of 2)
system to develop a prototype that could be used to help physical therapy patients comply with their prescribed strength and conditioning programs. The nonprofit medical research organization said it also plans to collaborate with the Naval Medical Center of San Diego in using the prototype to help wounded warriors and other patients.
—Skylight Healthcare Systems, a San Diego-based company developing interactive patient systems to support patient care before, during, and after a hospital stay, said they closed on $5 million in Series D funding from Duchossois Capital Partners, an affiliate of the Elmhurst, IL-based Duchossois Group. Skylight said it has reached profitability, and plans to use the funding to accelerate its growth and development.
—OncoSec Medical, a San Diego company developing electroporation technology to increase the concentration of an anti-cancer drug in solid tumor cancers, said the University of Washington (UW) will join UC San Francisco, the John Wayne Cancer Institute, and Lakeland Cancer Center as the fourth site for its mid-stage metastatic melanoma clinical trial. I previewed the technology earlier this year.